The Role of Glucocorticoid-Induced Phospholipase Inhibitory Proteins

  • Massimo Di Rosa
Part of the NATO ASI Series book series (NSSA, volume 95)


Glucocorticoids are powerful anti-inflammatory agents. Although their chief clinical utility in the treatment of acute and chronic inflammatory processes the knowledge of the mode of action of gluco -corticoids is still fragmentary. However at least some anti-inflammatory effects of glucocorticoids depend on their ability to prevent the formation of arachidonic acid oxidation products, i.e. the prostaglandins and leukotrienes which are important mediators of the inflammatory response. Glucocorticoids although do not inhibit cyclo-oxygenase or lipoxygenase are able to prevent phospholipid deacylation from occurring in intact cells by inhibiting phospholipase A2 thereby causing a shortage of precursor arachidonic acid.


Arachidonic Acid Systemic Lupus Erythematosus Patient Histiocytic Lymphoma Dibutyryl Adenosine Severe Rheumatic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.D. Baxter and G.M. Tomkins, Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells, Proc. natn. Acad. Sci. USA 68: 932 (1971).CrossRefGoogle Scholar
  2. 2.
    R.E. Buller and B.W. O’Malley, The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleus, Biochem. Pharmac. 25: 1 (1976).Google Scholar
  3. 3.
    L. Chan and B.W. O’Malley, Mechanism of action of the sex steroid hormones, New Engl. J. Med. 294: 1372 (1976).Google Scholar
  4. 4.
    A. Danon and G. Assouline, Inhibition of prostaglandins by corticosteroids requires RNA and protein synthesis. Nature, Lond. 273: 552 (1978).CrossRefGoogle Scholar
  5. 5.
    M. Di Rosa and P. Persico, Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes, Br. J. Pharmacol. 66: 161 (1979).PubMedGoogle Scholar
  6. 6.
    R.J. Flower and G.J. Blackwell, Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature Lond. 275: 456 (1979).CrossRefGoogle Scholar
  7. 7.
    R. Carnuccio, M. Di Rosa and P. Persico, Hydrocortisone induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br. J. Pharmacol. 68: 14 (1980).PubMedGoogle Scholar
  8. 8.
    G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, L. Parente and P. Persico, Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids, Nature Lond. 287: 147 (1980).PubMedCrossRefGoogle Scholar
  9. 9.
    F. Hirata, E. Schiffman, K. Venkatasubramanian, D. Salomon and J.A. Axelrod, Phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids Proc. natn. Acad. Sci. USA 77: 2535 (1980).Google Scholar
  10. 10.
    J.F. Cloix, 0. Colard, B. Rothhut and F. Russo-Marie,Characterization and partial purification of ‘renocortins’ two polypeptides formed in renal cells causing the antiphospholipase-like action of glucocorticoids, Br. J. Pharmacol. 79: 313 (1983).PubMedGoogle Scholar
  11. 11.
    G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, C.S.J. Langham, L. Parente, P. Persico, N.C. Russel-Smith and D. Stone, Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat, Br. J. Pharmacol. 76: 185 (1982).PubMedGoogle Scholar
  12. 12.
    F. Hirata, M. Notsu, M. Iwata, L. Parente, M. Di Rosa and J.R. Flower, Identification of several species of phospholipase inhibitory proteins by radioimmunoassay for lipomodulin, Biochem. biophys. Res. Commun. 109: 223 (1982).Google Scholar
  13. 13.
    P. Coote, M. Di Rosa, J.R. Flower, L. Parente, M. Merrett and J. Wood, Detection and isolation of a steroid-induced anti-phospholipase protein of high molecular weight, Br. J. Pharmacol. 80: 597 (1983).Google Scholar
  14. 14.
    B. Rothhut, F. Russo-Marie, J. Wood, M. Di Rosa and R.J. Flower, Further characterization of the glucocorticoidinduced anti-phospholipase protein ‘renocortin’, Biochem. biophys. Res. Commun. 117: 878 (1984).Google Scholar
  15. 15.
    G.J. Blackwell, Specificity and inhibition of glucocorticoidinduced macrocortin secretion from rat peritoneal macrophage, Br. J. Pharmac., 79: 587 (1983).Google Scholar
  16. 16.
    F. Hirata, The regulation of lipomodulin a phospholipase inhibitory protein in rabbit neutrophils by phosphorylation, J. Biol. Chem., 256: 7730 (1981).PubMedGoogle Scholar
  17. 17.
    L. Parente, M. Di Rosa, J.R. Flower, P. Ghiara, R. Meli, P. Persico, J.A. Salmon and J.N. Wood, Relationship between the anti-phospholipase and anti-inflammatory effect of glucocorticoid-induced proteins, Eur. J. Pharmac., 99: 233 (1984).CrossRefGoogle Scholar
  18. 18.
    A. Calignano, R. Carnuccio, M. Di Rosa, A. Ialenti and S. oncada, The anti-inflammatory effect of glucocorticoídinduced phospholipase inhibitory proteins, Agents and Actions (in press 1984).Google Scholar
  19. 19.
    M. Di Rosa and D.A. Willoughby, Screens for anti-inflammatory drugs, J. Pharm. Pharmac., 23: 297 (1971).CrossRefGoogle Scholar
  20. 20.
    T. Hattori, T. Hoffman and F. Hirata, Differentiation of a histiocytic lymphoma cell line by lipomodulin a phospholipase inhibitory protein, Biochem. Biophys. Res.Commun., 111: 551 (1983).CrossRefGoogle Scholar
  21. 21.
    T. Uede, F. Hirata, M. Hirashima and K. Ishizaka, Modulaton of the biological activities of IgE binding factors I. Identification of glycosilation-inhibiting factor as a fragment of lipomodulin, J. Immunol., 130: 878 (1983).PubMedGoogle Scholar
  22. 22.
    M. Koltai, I. Lepràn, G.Y. Nemecz and L. Szekeres, The possible mechanism of protection by dexamethasone against sudden death due to coronary ligation in conscious rats, Br. J. Pharmac., 79: 327 (1983).Google Scholar
  23. 23.
    F. Hirata, R. Del Carmine, C.A. Nelson, J. Axelrod, E. Schiff-mann, A. Warabi and Others, Presence of autoantibody for phospholipase inhibitory protein lipomodulin in patients with rheumatic diseases, Proc. natn. Acad. Sci. USA, 78: 3190 (1981).CrossRefGoogle Scholar
  24. 24.
    G. Ciabattoni, P. Patrignani, P. Filabozzi, A. Pierucci, B. Simonetti, G.A. Cinotti, E. Pinca, E. Gotti, G. Remuzzi and C. Patrono, Increased renal thromboxane (TX) production in systemic lupus erythematosus (SLE), Clin. Res., 30: 445A (1982).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Massimo Di Rosa
    • 1
  1. 1.Department of Experimental PharmacologyUniversity of NaplesItaly

Personalised recommendations